Keywords
SARS-CoV-2
Coronavirus
Diagnostic Tests for covid-19
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To describe the main types of coronavirus in humans reported in the literature and their diagnosis, in order to provide reliable guidance on this topic of great public health importance in the current context. Bibliographic review: Coronaviruses have been studied since the 1930s in episodes of infections among animals. The first case in humans was in 1960. The viruses with clinical repercussions in humans were SARS-CoV, MERS-CoV and SARS-CoV-2. covid-19 was the most aggressive, being responsible for millions of deaths worldwide. This disease has left traces of irreparable political, social, economic and public health damage, mitigated only after vaccination of the population. The disease prevention method continues to be based on diagnosis biosafety measures and vaccination. The gold standard in the diagnosis is configured in RT-PCR and the treatment has not yet been established with a consensus among researchers. Final considerations: The coronavirus has drawn the attention of scientists and laymen. Coronaviruses have been researched for decades, but with the threat to human health, the deepening of research on the subject has increased.
References
ALGHAMDI IG, et al. The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health. Int J Gen Med., 2014; 20(7): 417-23.
ANDERSEN KG, et al. A Origem Proximal do SARS-CoV-2. Nature Medicine, Inglaterra, 2020; 26: 450-452.
ARIAS LM. Decoding molnupiravir-induced mutagenesis in SARS-CoV-2. J. Biol. Chem., 2021.
BUTLER CC, et al. Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial. Lancet., 2023; 401(10373): 281-293.
CORONAVIRIDAE STUDY GROUP OF THE INTERNATIONAL COMMITTEE ON TAXONOMY OF VIRUSES - CSG. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, 2020: 5: 536–544.
DHAMA K, et al. Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies. J Infect Public Health, 2023; 16(1): 4-14.
DREXLER HL, et al. Revealing the processing dynamics of nascent RNA with nano-COP. Nat Protoc, 2021; 16: 1343–1375.
DROSTEN C, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. The New England journal of medicine, 2003; 348(20): 1967–1976.
ENJUANES L, et al. Encyclopedia of Virology, 2008; 419–30.
EZHILAN M, et al. SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge. Measurement (Lond), 2021; 168.
FERNANDES JL. Covid-19 no Brasil: Aprendendo a Andar no Escuro sem Deixar Nada para Trás. Arquivos Brasileiros de Cardiologia, v. 114, n. Arq. Bras. Cardiol., 2020; 114(6).
FORCHETTE L, et al. A Comprehensive Review of Virology, Vaccines, Variants, and COVID-19 Therapeutics. Current Medical Science, 2021; 41: 1037-1051.
FORNI G, et al. COVID-19 vaccines: where we stand and challenges ahead. Cell Death Differ, 2021; 28: 626–639.
GIOVANETTI M, et al. Evolution patterns of SARS-CoV-2: Snapshot on its genome variants. Biochem Biophys Res Commun, 2021; 29(538): 88-91.
GORBALENYA AE, et al. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbioly, 2020.
HATMAL MM, et al. Comprehensive structural and molecular comparison of SARS-CoV-2, SARS-CoV, and MERS-CoV spike proteins and their interactions with ACE2. Cells [Internet], 2020; 9(12): 1-37.
JACKSON CB, et al. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol, 2022.
KHALID S, et al. Current understanding of an Emerging Coronavirus using in silico approach: Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2). Braz J Biol [Internet], 2023; 83.
KIND L e CORDEIRO R. Narrativas sobre a morte: a gripe espanhola e a covid-19 no Brasil. Psicol Soc [Internet]. 2020; 32.
KNIPE DM e HOWLEY P. Fields Virology. Sixth Edition ed. 2013.
KSIAZEK TG, et al. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med., 2003; 1953 – 1966.
LIPPI G, et al. Updated picture of SARS-CoV-2 variants and mutations. Diagnosis, 2021; 9(1): 11-17.
MALIK YA. Properties of Coronavirus and SARS-CoV-2. Malays J Pathol., 2020.
MANOCHA, S et al. Severe acute respiratory syndrome (SARS): an intensive care perspective. Crit Care Med, 2003; 31: 11.
MOHAMADIAN M, et al. COVID-19: Virology, biology and novel laboratory diagnosis. J Gene Med., 2021.
NAJJAR-DEBBINY R, et al. “Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients.” Clinical infectious diseases: an official publication of the Infectious Diseases. Society of America., 2023; e342-e349.
NORMILE D. China is flying blind as the pandemic rages. Science, 2023; 379(6627): 11-12.
OMS, 2023. Global research on coronavirus disease (COVID-19). World Health Organization, 2020. Disponível em: https://www. who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov. Acessado em: 2 de janeiro de 2023.
PARRA-LUCARES A, et al. 2022. Emergence of SARS-CoV-2 Variants in the World: How Could This Happen? Life, 2022; 12(2): 194.
PEIRIS JSM, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. The Lancet, 2003; 361: 1319-1325.
RAMADAN N e SHAIB H. Middle East respiratory syndrome coronavirus (MERS-CoV): A review. Germs, 2019.
SNIJDER EJ, et al. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol., 2003: 331-991.
WANG Q, et al. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell., 2023; 186(2): 279-286.
WIT E, et al. SARS and MERS: insights into emerging coronaviruses. Nature Reviews Microbiology, 2016; 14(08): 523-534.
WOO PC, et al. Coronavirus diversity, phylogeny and interspecies jumping. Exp Biol Med (Maywood), 2009.
WU Z e McGOOGAN JM. Characterístics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China. JAMA, 2020; 323(13): 1239-1242.
YANG H e RAO Z. Structural biology of SARS-CoV-2 and implications for therapeutic development. Nat Rev Microbiol, 2021.
ZHOU F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 2020; 395(10229): 1054-1062.
ZHOU Z, et al. Role of COVID-19 Vaccines in SARS-CoV-2 Variants. Front Immunol., 2022; 20(13).
ZHU N, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New england jornal of medicine, 2019.
ZHU Z, et al. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res., 2020; 21(1): 224.